Pulse Biosciences CS
(NQ:
PLSE
)
21.48
-0.05 (-0.23%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pulse Biosciences CS
< Previous
1
2
3
4
5
6
7
8
9
Next >
12 Health Care Stocks Moving In Thursday's After-Market Session
March 28, 2024
Via
Benzinga
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results
March 28, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Announces Plans to Initiate a Rights Offering
March 28, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Schedules Fourth Quarter & Full Year 2023 Financial Results Conference Call for March 28, 2024
March 14, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Earnings Scheduled For March 28, 2024
March 28, 2024
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million.
Via
Benzinga
Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode System
March 08, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 11, 2024
Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart...
Via
Benzinga
Exposures
Product Safety
Pulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX® nsPFA™ 360° Cardiac Catheter First-in-Human Feasibility Study
February 14, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Announces Preliminary Findings from its CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study to be Featured in Podium Presentation at the AF Symposium
January 31, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday
January 02, 2024
U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX® nsPFA™ Cardiac Clamp
January 02, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Announces First-in-Human Procedures with its Novel CellFX™ Nanosecond Pulsed Field Ablation (nsPFA™) Cardiac Catheter
December 20, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
Tech Stocks Set New All-Time High, Small Caps On Fire As Wall Street Bulls Run Wild: What's Driving Markets Tuesday?
December 19, 2023
Tuesday, December 19, 2023, stands now as a remarkable day in Wall Street’s history, as the technology stocks of the Nasdaq 100 mark a significant milestone, surging to new highs after a hiatus of 758...
Via
Benzinga
$10M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
December 13, 2023
Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades.
Via
Benzinga
Insiders Buying Dave And 2 Other Stocks
December 07, 2023
Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades.
Via
Benzinga
Insiders Buying Westrock Coffee And 3 Other Stocks
December 04, 2023
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock....
Via
Benzinga
Agilent Posts Upbeat Results, Joins Burlington Stores, Hibbett And Other Big Stocks Moving Higher On Tuesday
November 21, 2023
U.S. stocks traded lower, with the Dow Jones falling around 90 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrode
November 21, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences to Present at the 35th Annual Piper Sandler Healthcare Conference
November 15, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Reports Business Updates and Third Quarter 2023 Financial Results
November 13, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
UPDATE Pulse Biosciences Announces New Time for Third Quarter 2023 Financial Results Conference Call
November 10, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Schedules Third Quarter 2023 Financial Results Conference Call for November 13, 2023
October 30, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
Earnings Scheduled For November 13, 2023
November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.
Via
Benzinga
Pulse Biosciences Appoints Dr. Niv Ad as Chief Science Officer, Cardiac Surgery
October 24, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Announces Collaboration with CardioNXT for nsPFA First-in-Human Atrial Fibrillation Study
October 02, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™) Circumferential Catheter System to be Featured in a Presentation at the Global EP Summit
September 29, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences’ First Study in a Surgical Application of Nanosecond Pulsed Field Ablation (nsPFA) Technology to be Featured in Two Poster Presentations at the American Thyroid Association Annual Meeting
September 27, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences to Present at Gilmartin Group Emerging Growth Showcase
September 07, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
The Truth About IPO Investing
September 02, 2023
When most companies go public, they are somewhat mature. Tech company initial public offerings, or IPOs, are a bit different, however. These companies are often not yet profitable. And biotech IPOs are...
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
12 Health Care Stocks Moving In Wednesday's Intraday Session
August 30, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.